Abstract
We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
Original language | English (US) |
---|---|
Pages (from-to) | 1053-1055 |
Number of pages | 3 |
Journal | Neurology |
Volume | 67 |
Issue number | 6 |
DOIs | |
State | Published - Sep 1 2006 |
Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. / Sugg, R. M.; Gonzales, N. R.; Matherne, D. E.; Ribo, M.; Shaltoni, Hashem; Baraniuk, S.; Noser, E. A.; Grotta, J. C.
In: Neurology, Vol. 67, No. 6, 01.09.2006, p. 1053-1055.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
AU - Sugg, R. M.
AU - Gonzales, N. R.
AU - Matherne, D. E.
AU - Ribo, M.
AU - Shaltoni, Hashem
AU - Baraniuk, S.
AU - Noser, E. A.
AU - Grotta, J. C.
PY - 2006/9/1
Y1 - 2006/9/1
N2 - We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
AB - We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
UR - http://www.scopus.com/inward/record.url?scp=33749019450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749019450&partnerID=8YFLogxK
U2 - 10.1212/01.wnl.0000239154.51331.c4
DO - 10.1212/01.wnl.0000239154.51331.c4
M3 - Article
C2 - 17000976
AN - SCOPUS:33749019450
VL - 67
SP - 1053
EP - 1055
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 6
ER -